Skip to main content

Dechra Value Stock - Dividend - Research Selection

Dechra Pharmaceuticals PLC

ISIN: GB0009633180, WKN: 578968

Market price date: 26.01.2022
Market price: 39,68 GBP


Dechra Pharmaceuticals PLC Fundamental data and company key figures of the share

Annual reports in GBP
Key figures 11-09-2021
Cash flow
Net operating cash flow 89.100.000
Capital Expenditures -18.900.000
Free cash flow 70.200.000
Balance sheet
Total Equity 632.900.000
Liabilities & Shareholders equity 1.214.100.000
Income statement
Net income 55.500.000
Eps (diluted) 0,513
Diluted shares outstanding 108.215.000
Net sales/revenue 608.000.000

Fundamental ratios calculated on: 26-01-2022

Ratios
Key figures 26-01-2022
Cash flow
P/C 48,19
   
P/FC 61,17
Balance sheet
ROI4,57
ROE52,13
Income statement
P/E77,35
Div. Yield1,02%
P/B6,79
P/S7,06


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolDPH.LSE
Market Capitalization5.652.937.216,00 USD
CountryUnited Kingdom
IndicesSTOXX EUROPE 600
SectorsPharmaceuticals
Raw Data SourceIFRS in Millionen GBP
Stock Split2012-04-30,1208.000000/1095.000000; 2007-12-12,734.000000/721.000000
Internetwww.dechra.com


Description of the company

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians worldwide. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.dechra.com


NEWS